| Synonyms: | |
| Status: | Approved (1970) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N01AX03 |
| UNII: | 690G0D6V8H |
| InChI Key | YQEZLKZALYSWHR-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C13H16ClNO |
| Molecular Weight | 237.73 |
| AlogP | 2.9 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 29.1 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 16.0 |
| Primary Target | |
|---|---|
| GluN2C |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
NMDA receptor
|
- | 610-10000 | - | 180-180 | - | |
|
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
- | 4950-11100 | - | - | 0 | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Two-pore domain potassium channel
|
- | - | - | - | 7 | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 1800 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Wounds and Injuries | 3 | D014947 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Postoperative Complications | 3 | D011183 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Obesity, Morbid | 3 | D009767 | ClinicalTrials |
| Suicidal Ideation | 3 | D059020 | ClinicalTrials |
| Anemia, Sickle Cell | 3 | D000755 | ClinicalTrials |
| Fractures, Bone | 3 | D050723 | ClinicalTrials |
| Bipolar Disorder | 3 | D001714 | ClinicalTrials |
| Neuralgia | 3 | D009437 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Alcoholism | 3 | D000437 | ClinicalTrials |
| Shock, Septic | 3 | D012772 | ClinicalTrials |
| Mucositis | 3 | D052016 | ClinicalTrials |
| Headache | 3 | D006261 | ClinicalTrials |
| Status Epilepticus | 3 | D013226 | ClinicalTrials |
| Status Asthmaticus | 3 | D013224 | ClinicalTrials |
| Delirium | 3 | D003693 | ClinicalTrials |
| Renal Colic | 3 | D056844 | ClinicalTrials |
| Chronic Pain | 3 | D059350 | ClinicalTrials |
| Depression, Postpartum | 3 | D019052 | ClinicalTrials |
| Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Pharyngitis | 3 | D010612 | ClinicalTrials |
| Rib Fractures | 3 | D012253 | ClinicalTrials |
| Bronchial Spasm | 2 | D001986 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Heart Septal Defects, Ventricular | 2 | D006345 | ClinicalTrials |
| Epilepsy | 2 | D004827 | ClinicalTrials |
| Coronavirus Infections | 2 | D018352 | ClinicalTrials |
| Obsessive-Compulsive Disorder | 2 | D009771 | ClinicalTrials |
| Temporomandibular Joint Disorders | 2 | D013705 | ClinicalTrials |
| Fractures, Multiple | 2 | D000069076 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Depressive Disorder, Treatment-Resistant | 2 | D061218 | ClinicalTrials |
| Respiratory Distress Syndrome | 2 | D012128 | ClinicalTrials |
| Complex Regional Pain Syndromes | 2 | D020918 | ClinicalTrials |
| Subarachnoid Hemorrhage | 2 | D013345 | ClinicalTrials |
| Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
| Paget Disease, Extramammary | 2 | D010145 | ClinicalTrials |
| Ischemic Stroke | 2 | D000083242 | ClinicalTrials |
| Borderline Personality Disorder | 2 | D001883 | ClinicalTrials |
| Hypertrophy | 2 | D006984 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Brain Injuries | 2 | D001930 | ClinicalTrials |
| Strabismus | 2 | D013285 | ClinicalTrials |
| Rett Syndrome | 2 | D015518 | ClinicalTrials |
| Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
| Marijuana Abuse | 1 | D002189 | ClinicalTrials |
| Schizophrenia | 1 | D012559 | ClinicalTrials |
| Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
| Cognitive Dysfunction | 1 | D060825 | ClinicalTrials |
| Sepsis | 1 | D018805 | ClinicalTrials |
| Fatigue | 1 | D005221 | ClinicalTrials |
| Tobacco Use Disorder | 1 | D014029 | ClinicalTrials |
| Heart Arrest | 1 | D006323 | ClinicalTrials |
| Mental Disorders | 1 | D001523 | ClinicalTrials |
| Opioid-Related Disorders | 1 | D009293 | ClinicalTrials |
| Perceptual Disorders | 1 | D010468 | ClinicalTrials |
| Stroke | 1 | D020521 | ClinicalTrials |
| Radius Fractures | 0 | D011885 | ClinicalTrials |
| Phobia, Social | 0 | D000072861 | ClinicalTrials |
| Hemorrhoids | 0 | D006484 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 6740-88-1 |
| ChEBI | 6121 |
| ChEMBL | CHEMBL742 |
| DrugBank | DB01221 |
| DrugCentral | 1523 |
| EPA CompTox | DTXSID8023187 |
| FDA SRS | 690G0D6V8H |
| Human Metabolome Database | HMDB0015352 |
| Guide to Pharmacology | 4233 |
| KEGG | C07525 |
| PharmGKB | PA450144 |
| PubChem | 3821 |
| SureChEMBL | SCHEMBL17084881 |